Our KEGG enrichment analysis results implied that another possible function of FGF9 in liver cancer is the activation of inflammation, a feature also associated with NASH.[51] This possibility is further supported by the expression of inflammatory factors, such as TNF‐α, IL‐6 and IL‐1β, in the livers of FGF9 TG mice. Here, FGF9 is linked to metabolic dysfunction-associated steatohepatitis.